Patent Assignment
Reel/Frame 041698/0404
Assignment of Assignor's Interest
Recorded: 2017-02-13
Pages: 40
Assignor
NEREUS PHARMACEUTICALS, INC.
Executed: 2012-10-23
Assignee
TRIPHASE RESEARCH AND DEVELOPMENT I CORP.
101 COLLEGE STREET, SUITE 340, TORONTO, M5G 1L7, CANADA
Covered Properties
(67)
Methods of using [3.2.0] heterocyclic compounds and analogs thereof
Application:
10/871,368 →
Publication:
US 2005/0049294
Use of salinosporamide A to treat LeTx intoxication and B, anthracis infection
Application:
60/480,270 →
Methods of using [3.2.0] heterocyclic compounds and analogs thereof
Application:
60/566,952 →
Methods of using [3.2.0] heterocyclic compounds and analogs thereof
Application:
60/633,379 →
Methods of using [3.2.0] heterocyclic compounds and analogs thereof
Application:
60/643,922 →
Methods of using [3.2.0] heterocyclic compounds and analogs thereof
Application:
60/658,884 →
Methods of using [3.2.0] heterocyclic compounds and analogs thereof
Application:
60/676,533 →
Methods of using [3.2.0] heterocyclic compounds and analogs thereof
Application:
11/412,476 →
Publication:
US 2006/0264495
[3.2.0] Heterocyclic compounds and methods of using the same
Application:
60/567,336 →
[3.2.0] Heterocyclic compounds and methods of using the same
Application:
60/580,838 →
[3.2.0] Heterocyclic compounds and methods of using the same
Application:
60/591,190 →
[3.2.0.] Heterocyclic compounds and methods of using the same
Application:
60/627,462 →
[3.2.0] Heterocyclic compounds and methods of using the same
Application:
60/644,132 →
[3.2.0] Heterocyclic compounds and methods of using the same
Application:
60/659,385 →
Methods of Sensitizing Cancer to Therapy-Induced Cytotoxicity
Application:
13/457,293 →
Publication:
US 2012/0282168
Methods of Sensitizing Cancer to Therapy-Induced Cytotoxicity
Application:
12/282,343 →
Publication:
US 2009/0148445
Methods of sensitizing cancer to therapy-induced cytotoxicity
Application:
60/733,965 →
Methods of sensitizing cancer to therapy-induced cytotoxicity
Application:
60/840,811 →
Biosyntheses of salinosporamide a and its analogs and related methods of making salinosporamide a and its analogs
Application:
60/715,404 →
Total synthesis of salinosporamide a and analogs thereof
Application:
60/790,168 →
Total synthesis of salinosporamide a and analogs thereof
Application:
60/816,968 →
Total synthesis of salinosporamide a and analogs thereof
Application:
60/836,155 →
Total synthesis of salinosporamide A and analogs thereof
Application:
60/844,132 →
Total Synthesis of Salinosporamide a and Analogs Thereof
Application:
60/885,379 →
Fermentation method
Application:
60/791,625 →
Methods of using [3.2.0] heterocyclic compounds and analogs thereof for the treatment of lung cancer
Application:
60/797,553 →
Biosyntheses of salinosporamide A and its analogs and related methods of making salinosporamide A and its analogs
Application:
60/816,771 →
Salt Formulations for the Fermentation of Marine Microorganisms
Salt formulations for the fermentation of marine microorganisms
Application:
60/846,774 →
Salt Formulations for the Fermentation of Marine Microorganisms
Application:
60/952,349 →
Lyophilized Formulations of Salinosporamide A
Application:
60/888,025 →
Lyophilized Formulations of Salinosporamide A
Application:
60/986,891 →
Fermentation Method for the Production of Marine Microorganisms
Application:
60/949,147 →
Fermentation Method for the Production of Marine Microorganisms
Application:
60/952,368 →
Method of Using Proteasome Inhibitors in Combination with Histone Deacetylase Inhibitors
Application:
60/910,623 →
Method of Using Proteasome Inhibitors in Combination with Histone Deacetylase Inhibitors
Application:
60/990,895 →
Methods of Using [3.2.0] Heterocyclic Compounds and Analogs Thereof for Treating Infectious Diseases
Application:
12/114,449 →
Publication:
US 2008/0280968
Methods of Using [3.2.0] Heterocyclic Compounds and Analogs Thereof for Treating Infectious Diseases
Application:
12/720,557 →
Publication:
US 2010/0168046
Methods of Using [3.2.0] Heterocyclic Compounds and Analogs Thereof for Treating Infectious Diseases
Application:
13/490,232 →
Publication:
US 2012/0264678
Methods of Using [3.2.0] Heterocyclic Compounds and Analogs Thereof for Treating Infectious Diseases
Application:
60/916,243 →
Methods of Using [3.2.0] Heterocyclic Compounds and Analogs Thereof in Treating Waldenstrom's Macroglobulinemia
Methods of Using [3.2.0] Heterocyclic Compounds and Analogs Thereof for Treating Waldenstrom's Macroglobulinemia
Application:
61/012,396 →
Total Synthesis of Salinosporamide a and Analogs Thereof
Total Synthesis of Salinosporamide a and Analogs Thereof
Application:
13/619,568 →
Publication:
US 2013/0012720
Total Synthesis of Salinosporamide A and Analogs Thereof
Application:
61/034,900 →
Total Synthesis of Salinosporamide a and Analogs Thereof
Application:
61/073,545 →
Use of Salinosporamide a to Inhibit Metastasis
Application:
12/423,713 →
Publication:
US 2009/0285836
Use of Salinosporamide a to Inhibit Metastasis
Application:
61/044,861 →
Use of Salinosporamide a to Inhibit Metastasis
Application:
61/057,631 →
Proteasome Inhibitors
Proteasome Inhibitors
Application:
61/052,576 →
Compositions and methods for treating neoplastic diseases
Application:
11/293,354 →
Publication:
US 2007/0225350
Compositions and Methods for Treating Neoplastic Diseases
Compositions and methods for treating neoplastic diseases
Application:
60/633,161 →
Compositions and Methods for Treating Neoplastic Diseases
Salt Formulations for the Fermentation of Marine Microorganisms
Methods of Using [3.2.0] Heterocyclic Compounds and Analogs Thereof
[3.2.0] Heterocyclic Compounds and Methods of Using the Same
[3.2.0] Heterocyclic Compounds and Methods of Using the Same
Methods of Using [3.2.0] Heterocyclic Compounds and Analogs Thereof
Biosyntheses of Salinosporamide a and Its Analogs and Related Methods of Making Salinosporamide a and Its Analogs
Total Synthesis of Salinosporamide a and Analogs Thereof
Total Synthesis of Salinosporamide a and Analogs Thereof
Lyophilized Formulations of Salinosporamide A
Total Synthesis of Salinosporamide a and Analogs Thereof
Proteasome Inhibitors
Proteasome Inhibitors
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Mortgage
Mar 12, 2004
From: PALLADINO, MICHAEL
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 014426/0325 →
Security Agreement
Aug 11, 2004
From: NEREUS PHARMACEUTICALS, INC.
To: ALTA CALIFORNIA PARTNERS II, L.P.; ALTA EMBARCADERO PARTNERS II, LLC; FORWARD VENTURES IV, L.P.; FORWARD VENTURES IV B, L.P.
Reel/Frame 015017/0484 →
Assignment of Assignor's Interest
Sep 14, 2004
From: POTTS, BARBARA C.; MACHERLA, VENKATA RAMI REDDY; NEUTEBOOM, SASKIA THEODORA CORNELIA; MITCHELL, SCOTT SHERMAN
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 015140/0439 →
Assignment of Assignor's Interest
Sep 14, 2004
From: POTTS, BARBARA C.; MACHERLA, VENKATA RAMI REDDY; NEUTEBOOM, SASKIA THEODORA CORNELIA
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 015140/0367 →
Assignment of Assignor's Interest
Mar 1, 2005
From: PALLADINO, MICHAEL; NEUTEBOOM, SASKIA THEODORA CORNELIA; MACHERLA, VENKATA RAMI REDDY; POTTS, BARBARA CHRISTINE
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 015809/0302 →
Assignment of Assignor's Interest
Jul 21, 2006
From: PALLADINO, MICHAEL; POTTS, BARBARA CHRISTINE; MACHERLA, VENKATA RAMI REDDY; NEUTEBOOM, SASKIA THEODORA CORNELIA
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 017987/0665 →
Assignment of Assignor's Interest
Aug 16, 2006
From: BONAVIDA, BENJAMIN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 018123/0422 →
Assignment of Assignor's Interest
Aug 16, 2006
From: PALLADINO, MICHAEL A.
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 018123/0577 →
Assignment of Assignor's Interest
Sep 15, 2006
From: LING, TAOTAO; MACHERLA, VENKATA RAMI REDDY; POTTS, BARBARA CHRISTINE; MANAM, RAMA RAO
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 018276/0357 →
Assignment of Assignor's Interest
Sep 15, 2006
From: LING, TAOTAO; MACHERLA, VENKATA RAMI REDDY; POTTS, BARBARA CHRISTINE; MANAM, RAMA RAO
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 018276/0166 →
Assignment of Assignor's Interest
Jul 16, 2007
From: LING, TAOTAO; MACHERLA, VENKATA RAMI REDDY; POTTS, BARBARA CHRISTINE; MANAM, RAMA RAO
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 019564/0820 →
Assignment of Assignor's Interest
Jul 16, 2007
From: LING, TAOTAO; MACHERLA, VENKATA RAMI REDDY; POTTS, BARBARA CHRISTINE; MANAM, RAMA RAO
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 019564/0843 →
Assignment of Assignor's Interest
Jul 16, 2007
From: LING, TAOTAO; MACHERLA, VENKATA RAMI REDDY; POTTS, BARBARA CHRISTINE; MANAM, RAMA RAO
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 019564/0813 →
Assignment of Assignor's Interest
Feb 19, 2008
From: LAM, KIN SING; TSUENG, GINGER
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 020529/0853 →
Assignment of Assignor's Interest
Jul 2, 2008
From: PALLADINO, MICHAEL
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 021191/0050 →
Assignment of Assignor's Interest
Feb 27, 2009
From: PALLADINO, MICHAEL
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 022333/0834 →
Security Agreement
May 21, 2009
From: NEREUS PHARMACEUTICALS, INC.
To: HBM BIOVENTURES (CAYMAN) LTD.; HBM BIOCAPITAL (EUR) L.P.; HBM BIOCAPITAL (USD) L.P.; PRIVATE LIFE BIOMED AG
Reel/Frame 022719/0115 →
Assignment of Assignor's Interest
Oct 1, 2009
From: BONAVIDA, BENJAMIN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 023313/0246 →
Assignment of Assignor's Interest
Apr 6, 2011
From: PALLADINO, MICHAEL A.
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 026082/0113 →
Assignment of Assignor's Interest
May 16, 2012
From: PALLADINO, MICHAEL
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 028219/0150 →
Assignment of Assignor's Interest
Feb 28, 2013
From: NEREUS PHARMACEUTICALS, INC.
To: TRIPHASE RESEARCH AND DEVELOPMENT I CORP.
Reel/Frame 029899/0101 →
Release of Security Interest
Nov 15, 2016
From: HBM VIOVENTURES (CAYMAN) LTD.; HBM BIOCAPITAL (EUR) L.P.; HBM BIOCAPITAL (USD) L.P.; PRIVATE LIFE BIOMED AG
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 040327/0264 →
Assignment of Assignor's Interest
Jun 11, 2018
From: CELGENE TRI A HOLDINGS LTD.
To: CELGENE INTERNATIONAL II SARL
Reel/Frame 046047/0260 →
Assignment of Assignor's Interest
Apr 29, 2024
From: CELGENE TRI A HOLDINGS LTD.
To: CELGENE INTERNATIONAL II SARL
Reel/Frame 067256/0305 →
Assignment of Assignor's Interest
Apr 29, 2024
From: 1096271 B.C. UNLIMITED LIABILITY COMPANY
To: CELGENE TRI A HOLDINGS LTD.
Reel/Frame 067256/0286 →